4/1/2024 0 Comments Ms agent fox![]() ![]() Mykol Larvie, the Cleveland Clinic’s director of functional neuroimaging, added that Myeliviz could be used to monitor “brain health in general,” and to help evaluate the effectiveness of treatments in “numerous neurological diseases such as epilepsy, stroke, neurodegeneration, tumor and trauma in the brain and spinal cord. “Myeliviz could be the missing link in finding a cure for MS and other myelin diseases by serving as a specific and quantitative imaging marker for early diagnosis and sensitive, quantitative evaluation of novel therapies currently under development,” said Chunying Wu, Myeliviz’s co-inventor and an instructor of radiology at Case Western. E-Mail: To protect agents from spam, email addresses are hidden except to logged-in members. Early stages of MS are more responsive to neuroprotective therapies. Researchers believe that Myeliviz could help in the development of new MS therapies as a measure of treatment effectiveness, and may significantly aid in slowing disease progression, as treatment could be started earlier. The clinical program of Myeliviz is being supported by a $1.6 million grant from the National Institutes of Health, with Wang and Fox as the grant’s co-principal investigators. ![]() The researchers anticipate that positive results from this trial will support a Phase 2 study in MS patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |